Solid Biosciences (SLDB) EPS (Weighted Average and Diluted) (2020 - 2024)
Historic EPS (Weighted Average and Diluted) for Solid Biosciences (SLDB) over the last 4 years, with Q4 2024 value amounting to -$1.02.
- Solid Biosciences' EPS (Weighted Average and Diluted) fell 200.0% to -$1.02 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.06, marking a year-over-year increase of 3677.69%. This contributed to the annual value of -$3.06 for FY2024, which is 3664.6% up from last year.
- Latest data reveals that Solid Biosciences reported EPS (Weighted Average and Diluted) of -$1.02 as of Q4 2024, which was down 200.0% from -$0.79 recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' EPS (Weighted Average and Diluted) ranged from a high of -$0.61 in Q2 2024 and a low of -$6.17 during Q4 2020
- Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$1.04 (2023), whereas its average is -$1.73.
- Examining YoY changes over the last 5 years, Solid Biosciences' EPS (Weighted Average and Diluted) showed a top increase of 6246.25% in 2023 and a maximum decrease of 4705.88% in 2023.
- Quarter analysis of 4 years shows Solid Biosciences' EPS (Weighted Average and Diluted) stood at -$6.17 in 2020, then surged by 88.98% to -$0.68 in 2022, then tumbled by 47.06% to -$1.0 in 2023, then dropped by 2.0% to -$1.02 in 2024.
- Its EPS (Weighted Average and Diluted) stands at -$1.02 for Q4 2024, versus -$0.79 for Q3 2024 and -$0.61 for Q2 2024.